ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,650, issued on Nov. 11, was assigned to THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas).
"Methods and compositions for targeting cancer cells in metastases" was invented by Mikhail Kolonin (Houston), Alexes Daquinag (Houston) and Shraddha Subramanian (Houston).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions are presented for use in diagnostic, imaging or targeting of therapeutic agents to treat cancer cells in metastases, such as where compositions and methods identify and employ peptides to selectively target cancer cells in metastases in mammals, both in vitro and in vivo."
The patent was filed on Aug...